Furthermore, we reveal that NP-G2-044 decreases the cell proliferation and primary tumor growth of activated B-cell diffuse large B-cell lymphoma, diffuse mixed lineage lymphoma, and epidermal growth factor receptor (EGFR)-high triple-negative breast cancer. This evidence concerns the gene EGFR and diffuse large B-cell lymphoma.